Reham Soliman

Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4

Wahid Doss, Gamal Shiha, Mohamed Hassany et al. · Journal of Hepatology · 2015 · 145 citations

Hepatology, Hepatitis C, Viral Hepatitis +8

Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial

Imam Waked, Gamal Shiha, Roula Qaqish et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 73 citations

Open-label Trial, Hepatology, Hepatitis C +9

An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project

Gamal Shiha, Ammal M. Metwally, Reham Soliman et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 66 citations

Vaccination, Preventive Medicine, Hepatitis C +9

Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study

Gamal Shiha, Nasser Mousa, Reham Soliman et al. · Journal of Viral Hepatitis · 2020 · 65 citations

GES: A validated simple score to predict the risk of HCC in patients with HCV‐GT4‐associated advanced liver fibrosis after oral antivirals

Gamal Shiha, Imam Waked, Reham Soliman et al. · Liver International · 2020 · 52 citations